Recognition of Coxiella burnetii by toll-like receptors and nucleotide-binding oligomerization domain-like receptors.
暂无分享,去创建一个
M. Oosting | L. Joosten | M. Netea | J. Rebel | D. D. de Jong | M. Gresnigt | M. van Deuren | T. Sprong | T. Kanneganti | M. D. den Brok | S. Abdollahi-Roodsaz | H. Roest | T. Schoffelen | A. Ammerdorffer
[1] M. Oosting,et al. TLR1, TLR2, and TLR6 gene polymorphisms are associated with increased susceptibility to complicated skin and skin structure infections. , 2014, The Journal of infectious diseases.
[2] J. Oosterheert,et al. Delayed Diagnosis of Chronic Q Fever and Cardiac Valve Surgery , 2013, Emerging infectious diseases.
[3] T. Miyakawa,et al. Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013 .
[4] Alexander Hoischen,et al. Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans , 2013, Nature Communications.
[5] J. Rebel,et al. Q Fever in Pregnant Goats: Pathogenesis and Excretion of Coxiella burnetii , 2012, PloS one.
[6] M. Oosting,et al. Toll-like receptor 1 polymorphisms increase susceptibility to candidemia. , 2012, The Journal of infectious diseases.
[7] L. Joosten,et al. Neisseria meningitidis lipid A mutant LPSs function as LPS antagonists in humans by inhibiting TLR 4-dependent cytokine production , 2011, Innate immunity.
[8] F. V. van Zijderveld,et al. Molecular Epidemiology of Coxiella burnetii from Ruminants in Q Fever Outbreak, the Netherlands , 2011, Emerging infectious diseases.
[9] M. Oosting,et al. Recognition of Borrelia burgdorferi by NOD2 is central for the induction of an inflammatory reaction. , 2010, The Journal of infectious diseases.
[10] G. E. Etokebe,et al. Toll‐Like Receptor 2 (P631H) Mutant Impairs Membrane Internalization and is a Dominant Negative Allele , 2010, Scandinavian journal of immunology.
[11] J. Mege,et al. Role of the cytoplasmic pattern recognition receptor Nod2 in Coxiella burnetii infection. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[12] M. Rieder,et al. Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. , 2008, American journal of respiratory and critical care medicine.
[13] J. Kalil,et al. Variants in the toll-like receptor signaling pathway and clinical outcomes of malaria. , 2008, The Journal of infectious diseases.
[14] Richard D. Wells,et al. Human TLR1 Deficiency Is Associated with Impaired Mycobacterial Signaling and Protection from Leprosy Reversal Reaction , 2008, PLoS neglected tropical diseases.
[15] M. Netea,et al. Mycobacterium paratuberculosis is recognized by Toll‐like receptors and NOD2 , 2007, Journal of leukocyte biology.
[16] J. Ochoa-Repáraz,et al. Attenuated Coxiella burnetii Phase II Causes a Febrile Response in Gamma Interferon Knockout and Toll-Like Receptor 2 Knockout Mice and Protects against Reinfection , 2007, Infection and Immunity.
[17] L. Joosten,et al. Bartonella quintana Lipopolysaccharide Is a Natural Antagonist of Toll-Like Receptor 4 , 2007, Infection and Immunity.
[18] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[19] D. Raoult,et al. TLR2 Is Necessary to Inflammatory Response in Coxiella burnetii Infection , 2005, Annals of the New York Academy of Sciences.
[20] J. Satagopan,et al. TLR1 and TLR6 Polymorphisms Are Associated with Susceptibility to Invasive Aspergillosis after Allogeneic Stem Cell Transplantation , 2005, Annals of the New York Academy of Sciences.
[21] M. Netea,et al. NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype. , 2005, The Netherlands journal of medicine.
[22] D. Raoult,et al. Natural history and pathophysiology of Q fever. , 2005, The Lancet. Infectious diseases.
[23] I. C. Almeida,et al. Stimulation of Toll-like Receptor 2 by Coxiella burnetii Is Required for Macrophage Production of Pro-inflammatory Cytokines and Resistance to Infection* , 2004, Journal of Biological Chemistry.
[24] S. Akira,et al. Lipopolysaccharide from Coxiella burnetii Is Involved in Bacterial Phagocytosis, Filamentous Actin Reorganization, and Inflammatory Responses through Toll-Like Receptor 41 , 2004, The Journal of Immunology.
[25] C. Hughes,et al. Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.
[26] R. Toman,et al. Structural Properties of Lipopolysaccharides from Coxiella burnetii Strains Henzerling and S , 2003, Annals of the New York Academy of Sciences.
[27] S. Akira,et al. Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins1 , 2002, The Journal of Immunology.
[28] C. Janeway,et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems , 2002, Nature.
[29] Huitu Liu,et al. MAPK signal pathways in the regulation of cell proliferation in mammalian cells , 2002, Cell Research.
[30] Ruslan Medzhitov,et al. Toll-like receptors and innate immunity , 2001, Nature Reviews Immunology.
[31] S. Akira,et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. , 2001, International immunology.
[32] D. Raoult,et al. Interleukin-10 Stimulates Coxiella burnetiiReplication in Human Monocytes through Tumor Necrosis Factor Down-Modulation: Role in Microbicidal Defect of Q Fever , 2001, Infection and Immunity.
[33] A. Aderem,et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[34] D. Golenbock,et al. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. , 1991, The Journal of biological chemistry.
[35] P. Hitchcock,et al. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels , 1983, Journal of bacteriology.
[36] C. Galanos,et al. Lipid A component of lipopolysaccharides from Coxiella burnetii. , 1981, Acta virologica.
[37] G. Argast,et al. Inhibition of RIP2/RICK/CARDIAK activity by pyridinyl imidazole inhibitors of p38 MAPK , 2005, Molecular and Cellular Biochemistry.